254 related articles for article (PubMed ID: 15060752)
1. Splenic marginal zone lymphoma presenting as myelofibrosis associated with bone marrow involvement of lymphoma cells which secrete a large amount of TGF-beta.
Matsunaga T; Takemoto N; Miyajima N; Okuda T; Nagashima H; Sato T; Terui T; Sasaki H; Ohmi N; Hirayama Y; Tamura Y; Niitsu Y
Ann Hematol; 2004 May; 83(5):322-5. PubMed ID: 15060752
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
[TBL] [Abstract][Full Text] [Related]
4. Splenic marginal zone cell lymphoma involving liver and bone marrow. Report of a case with protracted follow-up, showing progressive disappearance of the lymphoma after splenectomy.
Rosso R; Castello A; Colosini G; Astori C; Lazzarino M; Magrini U
Haematologica; 1996; 81(1):44-6. PubMed ID: 8900851
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development.
Gastinne T; Vigant F; Lavenu-Bombled C; Wagner-Ballon O; Tulliez M; Chagraoui H; Villeval JL; Lacout C; Perricaudet M; Vainchenker W; Benihoud K; Giraudier S
Exp Hematol; 2007 Jan; 35(1):64-74. PubMed ID: 17198875
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
[TBL] [Abstract][Full Text] [Related]
7. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T-cell lymphoma presenting as myelofibrosis with the expression of basic fibroblast growth factor.
Kikukawa M; Umahara T; Kikawada M; Kanaya K; Sakurai H; Shin K; Mori M; Iwamoto T
Geriatr Gerontol Int; 2009 Dec; 9(4):395-8. PubMed ID: 20002760
[TBL] [Abstract][Full Text] [Related]
9. CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma.
Franco V; Florena AM; Ascani S; Paulli M; Salvato M; Pileri SA
Histopathology; 2004 Apr; 44(4):381-6. PubMed ID: 15049905
[TBL] [Abstract][Full Text] [Related]
10. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
11. [Peripheral T-cell lymphoma initially presenting as secondary myelofibrosis].
Takai K; Sanada M
Rinsho Ketsueki; 1989 Dec; 30(12):2199-204. PubMed ID: 2695663
[TBL] [Abstract][Full Text] [Related]
12. [Primary splenic lymphoma with hypoplastic bone marrow].
Yoshioka Y; Kawamata N; Sato E; Isobe Y; Oshimi K
Rinsho Ketsueki; 1999 Feb; 40(2):124-8. PubMed ID: 10199206
[TBL] [Abstract][Full Text] [Related]
13. A case of splenic lymphoma with marked diffuse nodular fibrosis and calcification, complicated with severe autoimmune hemolytic anemia.
Yamazaki K
J Submicrosc Cytol Pathol; 2003 Jan; 35(1):17-23. PubMed ID: 12762647
[TBL] [Abstract][Full Text] [Related]
14. Primary lymphoma of the spleen. Report of a case with diagnosis by fine-needle guided biopsy.
Cavanna L; Artioli F; Vallisa D; Di Donato C; Bertè R; Carapezzi C; Foroni R; Del Vecchio C; Lo Monaco B; Prati R
Haematologica; 1995; 80(3):241-3. PubMed ID: 7672717
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis.
Kawakami T; Kimura S; Kato M; Mizoguchi M; Soma Y
J Am Acad Dermatol; 2008 Apr; 58(4):703-6. PubMed ID: 18342720
[TBL] [Abstract][Full Text] [Related]
16. [TGF-beta and platelet].
Kogawa K; Mogi Y; Morii K; Takimoto R; Niitsu Y
Rinsho Ketsueki; 1994 Apr; 35(4):370-5. PubMed ID: 8028182
[TBL] [Abstract][Full Text] [Related]
17. Primary splenic lymphoma in patient with hepatitis C virus infection: case report and review of the literature.
Matone J; Lopes Filho GD; Scalabrin M; Ricca AB; Sato NY
Int Surg; 2000; 85(3):248-51. PubMed ID: 11325005
[TBL] [Abstract][Full Text] [Related]
18. [Lymphoma of the marginal zone of the spleen. A case study].
Navarro JT; Ribera JM; Pérez-Piteira J; Vaquero M; Zarco MA; Juncá J; Granada I; Millá F; Feliu E
Med Clin (Barc); 1996 Feb; 106(4):141-3. PubMed ID: 8948931
[TBL] [Abstract][Full Text] [Related]
19. Pathologic-spontaneous-rupture of the spleen as a presenting sign of splenic T-cell lymphoma--case report with review.
Haj M; Zaina A; Wiess M; Cohen I; Joseph M; Horn I; Eitan A
Hepatogastroenterology; 1999; 46(25):193-5. PubMed ID: 10228790
[TBL] [Abstract][Full Text] [Related]
20. Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study.
Pich A; Fraire F; Fornari A; Bonino LD; Godio L; Bortolin P; Chiusa L; Palestro G
Eur J Haematol; 2006 May; 76(5):392-8. PubMed ID: 16480431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
